Caricamento...
Current treatment options of brain metastases and outcomes in patients with malignant melanoma
The prognosis for patients with melanoma who have brain metastases is poor, a median survival does not exceed 4–6 months. There are no uniform standards of treatment for patients with melanoma brain metastases (MBMs). The most preferred treatment approaches include local therapy – surgical resection...
Salvato in:
| Pubblicato in: | Rep Pract Oncol Radiother |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Elsevier
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5002030/ https://ncbi.nlm.nih.gov/pubmed/27601961 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.rpor.2015.12.001 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|